Canada markets closed

Genix Pharmaceuticals Corporation (GENX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.06000.0000 (0.00%)
At close: 03:53PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-10-31
2022-10-31
2021-10-31
2020-10-31
Total Revenue
10.836
12.347
0
0
0
Cost of Revenue
8.34
9.084
0
-
0
Gross Profit
2.496
3.263
0
-
0
Operating Expenses
Selling General and Administrative
237.108
278.828
425.324
1,054
334.724
Total Operating Expenses
703.935
884.157
1,031
1,655
715.205
Operating Income or Loss
-701.439
-880.894
-1,031
-1,655
-715.205
Interest Expense
67.28
50.978
10.747
3.509
3.882
Total Other Income/Expenses Net
-3,458
-3,463
-30.797
4.472
-0.008
Income Before Tax
-4,228
-4,396
-1,074
-1,653
-718.663
Income from Continuing Operations
-4,228
-4,396
-1,074
-1,653
-718.663
Net Income
-4,228
-4,396
-1,074
-1,653
-718.663
Net Income available to common shareholders
-4,228
-4,396
-1,074
-1,653
-718.663
Basic EPS
-0.02
-
-0.02
-0.03
-0.02
Diluted EPS
-0.02
-
-0.02
-0.03
-0.02
Basic Average Shares
59,224
-
59,224
59,224
49,958
Diluted Average Shares
59,224
-
59,224
59,224
49,958